ES8400102A1 - Procedimiento para la obtencion de azoles 2,4,5-trisustituidos. - Google Patents

Procedimiento para la obtencion de azoles 2,4,5-trisustituidos.

Info

Publication number
ES8400102A1
ES8400102A1 ES510504A ES510504A ES8400102A1 ES 8400102 A1 ES8400102 A1 ES 8400102A1 ES 510504 A ES510504 A ES 510504A ES 510504 A ES510504 A ES 510504A ES 8400102 A1 ES8400102 A1 ES 8400102A1
Authority
ES
Spain
Prior art keywords
processes
preparation
medicaments containing
thiazole derivatives
dissociable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES510504A
Other languages
English (en)
Other versions
ES510504A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES510504A0 publication Critical patent/ES510504A0/es
Publication of ES8400102A1 publication Critical patent/ES8400102A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/36—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE AZOLES 2,4,5-TRISUSTITUIDOS.SE PARTE DE UN COMPUESTO (II) DONDE UNO DE LOS RESTOS Y1 E Y2 ES UN RESTO Y DISOCIABLE Y EL OTRO ES UN ATOMO DE HIDROGENO; Y3 E Y4 JUNTOS REPRESENTAN UN ENLACE ADICIONAL O DONDE Y4 ES UN RESTO DISOCIABLE E Y3 ES HIDROGENO, AL QUE SE INTRODUCE UN ENLACE ADICIONAL; SI ES NECESARIO, LA MEZCLA DE ISOMEROS OBTENIDOS SE SEPARA EN LOS ISOMEROS PUROS O BIEN SE TRANSFORMA EN OTRO COMPUESTO (I) O BIEN EN LA SAL DE ADICION CORRESPONDIENTE.
ES510504A 1981-03-18 1982-03-17 Procedimiento para la obtencion de azoles 2,4,5-trisustituidos. Expired ES8400102A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH183881 1981-03-18

Publications (2)

Publication Number Publication Date
ES510504A0 ES510504A0 (es) 1983-10-16
ES8400102A1 true ES8400102A1 (es) 1983-10-16

Family

ID=4219779

Family Applications (8)

Application Number Title Priority Date Filing Date
ES510504A Expired ES8400102A1 (es) 1981-03-18 1982-03-17 Procedimiento para la obtencion de azoles 2,4,5-trisustituidos.
ES522869A Granted ES522869A0 (es) 1981-03-18 1983-05-31 Procedimiento para la obtencion de azoles 2,4,5-trisustituidos. (como desglose y con prioridad de la patente espanola no.510.504, presentada el 17 de marzo de 1.982).
ES522868A Granted ES522868A0 (es) 1981-03-18 1983-05-31 Procedimiento para la obtencion de azoles 2,4,5-trisustituidos. (como desglose y con prioridad de la patente espanola no.510.504, presentada el 17 de marzo de 1.982)
ES522867A Granted ES522867A0 (es) 1981-03-18 1983-05-31 Procedimiento para la obtencion de azoles 2,4,5-trisustituidos. (como desglose y con prioridad de la patente espanola no.510.504, presentada el 17 de marzo de 1.982)
ES537278A Granted ES537278A0 (es) 1981-03-18 1984-10-31 Procedimiento para la obtencion de azoles 2,4,5-trisustituidos.
ES537277A Granted ES537277A0 (es) 1981-03-18 1984-10-31 Procedimiento para la obtencion de azoles 2,4,5-trisustituidos.
ES537342A Expired ES8604180A1 (es) 1981-03-18 1984-11-02 Procedimiento para la obtencion de azoles 2, 4, 5-trisustituidos
ES537343A Granted ES537343A0 (es) 1981-03-18 1984-11-02 Procedimiento para la obtencion de azoles 2, 4, 5-trisustituidos

Family Applications After (7)

Application Number Title Priority Date Filing Date
ES522869A Granted ES522869A0 (es) 1981-03-18 1983-05-31 Procedimiento para la obtencion de azoles 2,4,5-trisustituidos. (como desglose y con prioridad de la patente espanola no.510.504, presentada el 17 de marzo de 1.982).
ES522868A Granted ES522868A0 (es) 1981-03-18 1983-05-31 Procedimiento para la obtencion de azoles 2,4,5-trisustituidos. (como desglose y con prioridad de la patente espanola no.510.504, presentada el 17 de marzo de 1.982)
ES522867A Granted ES522867A0 (es) 1981-03-18 1983-05-31 Procedimiento para la obtencion de azoles 2,4,5-trisustituidos. (como desglose y con prioridad de la patente espanola no.510.504, presentada el 17 de marzo de 1.982)
ES537278A Granted ES537278A0 (es) 1981-03-18 1984-10-31 Procedimiento para la obtencion de azoles 2,4,5-trisustituidos.
ES537277A Granted ES537277A0 (es) 1981-03-18 1984-10-31 Procedimiento para la obtencion de azoles 2,4,5-trisustituidos.
ES537342A Expired ES8604180A1 (es) 1981-03-18 1984-11-02 Procedimiento para la obtencion de azoles 2, 4, 5-trisustituidos
ES537343A Granted ES537343A0 (es) 1981-03-18 1984-11-02 Procedimiento para la obtencion de azoles 2, 4, 5-trisustituidos

Country Status (16)

Country Link
US (1) US4451471A (es)
EP (1) EP0061425A3 (es)
JP (1) JPS57183767A (es)
KR (1) KR830009066A (es)
AU (1) AU8166782A (es)
DK (1) DK118482A (es)
ES (8) ES8400102A1 (es)
FI (1) FI820877L (es)
GB (1) GB2098203B (es)
GR (1) GR78347B (es)
HU (1) HU187684B (es)
IL (1) IL65285A (es)
NO (1) NO820881L (es)
NZ (1) NZ200038A (es)
PT (1) PT74593B (es)
ZA (1) ZA821790B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4632930A (en) * 1984-11-30 1986-12-30 E. I. Du Pont De Nemours And Company Antihypertensive alkyl-arylimidazole, thiazole and oxazole derivatives
DE3508665A1 (de) * 1985-03-12 1986-09-18 Hoechst Ag, 6230 Frankfurt Heterocyclische sulfide und ihre anwendung als immunmodulatoren
DE3508666A1 (de) * 1985-03-12 1986-09-18 Hoechst Ag, 6230 Frankfurt Heterocyclische disulfide und ihre anwendung als immunmodulatoren
JPS6339868A (ja) * 1986-08-04 1988-02-20 Otsuka Pharmaceut Factory Inc ジ低級アルキルフエノ−ル誘導体
ES2038279T3 (es) * 1987-07-27 1993-07-16 Duphar International Research B.V Metodo para preparar compuestos de tiazol.
AT392788B (de) * 1988-02-03 1991-06-10 Fisons Plc Neue benzimidazolverbindungen, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen
DE3807232A1 (de) * 1988-03-05 1989-09-14 Bayer Ag Substituierte acrylsaeureester
JP2933739B2 (ja) * 1990-04-09 1999-08-16 明治製菓株式会社 チアゾールまたはイミダゾール誘導体および抗潰瘍剤
US5255697A (en) * 1991-10-23 1993-10-26 Working Inc. Walking support apparatus
AU679626B2 (en) * 1994-03-08 1997-07-03 Wyeth Thiazolidinedione derivatives as anti-hyperglycemic agents
JP2636819B2 (ja) 1994-12-20 1997-07-30 日本たばこ産業株式会社 オキサゾール系複素環式芳香族化合物
WO2001010865A1 (en) * 1999-08-06 2001-02-15 Takeda Chemical Industries, Ltd. p38MAP KINASE INHIBITORS
CN101421265A (zh) * 2006-01-18 2009-04-29 安姆根有限公司 作为蛋白激酶b(pkb)抑制剂的噻唑化合物
WO2009011871A2 (en) * 2007-07-17 2009-01-22 Amgen Inc. Thiadiazole modulators of pkb
RU2638537C2 (ru) 2012-07-12 2017-12-14 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Ингибирование ферментов

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2129012A1 (de) * 1971-06-11 1973-01-04 Merck Patent Gmbh Azol-derivate
FR2146161A1 (en) * 1971-07-22 1973-03-02 Roussel Uclaf Thiazolyl thiolacetic acids - analgesics antiinflammatories and antipyretics
US3888870A (en) * 1974-03-08 1975-06-10 Sandoz Ag 2-sulfinyl-thiazoles and oxazoles
US4022607A (en) * 1975-06-09 1977-05-10 Sandoz, Inc. Substituted oxazoles and thiazoles as herbicides

Also Published As

Publication number Publication date
KR830009066A (ko) 1983-12-17
NZ200038A (en) 1985-05-31
ES8601171A1 (es) 1985-10-16
DK118482A (da) 1982-09-19
GB2098203B (en) 1985-05-09
ES8603499A1 (es) 1985-12-16
ES8603498A1 (es) 1985-12-16
NO820881L (no) 1982-09-20
US4451471A (en) 1984-05-29
ES8502980A1 (es) 1985-02-01
ES8503677A1 (es) 1985-03-16
EP0061425A2 (de) 1982-09-29
ES8603847A1 (es) 1986-01-01
ES8604180A1 (es) 1986-01-16
ES522867A0 (es) 1985-12-16
PT74593B (de) 1984-11-27
ES537342A0 (es) 1986-01-16
ES537277A0 (es) 1986-01-01
GR78347B (es) 1984-09-26
AU8166782A (en) 1982-09-23
ES537278A0 (es) 1985-12-16
ES522869A0 (es) 1985-03-16
IL65285A (en) 1985-11-29
ES522868A0 (es) 1985-02-01
FI820877A7 (fi) 1982-09-19
IL65285A0 (en) 1982-05-31
ZA821790B (en) 1983-01-26
EP0061425A3 (de) 1982-12-15
ES510504A0 (es) 1983-10-16
JPS57183767A (en) 1982-11-12
HU187684B (en) 1986-02-28
GB2098203A (en) 1982-11-17
PT74593A (de) 1982-04-01
ES537343A0 (es) 1985-10-16
FI820877L (fi) 1982-09-19

Similar Documents

Publication Publication Date Title
KR920018029A (ko) 신규한 카복실산 아미드
GT199900119A (es) Jarabe antihistaminico estabilizado.
MX9301032A (es) Compuestos farmaceuticos y procedimento para su preparacion
MX167182B (es) Compuestos de imidazol y composicion biocida que los comprende, para controlar organismos dañinos
ES2174989T3 (es) Pirido(3,2-e)pirazinonas con antiasmatica y procedimiento para su preparacion.
AU6954887A (en) Oligopeptidyl nitrile derivatives, agents containing them, a process for their preparation, and their use
DK0564350T3 (da) 3, 5-di-tert-butyl-4-hydroxyflavoner, fremgangsmåde til deres fremstilling og farmaceutiske sammensætninger med antioxidant- og anti-vasokonstriktorisk virkning
NO832125L (no) Sprengstoffblanding av emulsjonstype, samt fremgangsmaate for fremstilling av en slik
CO4950531A1 (es) Analogos de la vitamina d3 composciiones farmaceuticas que los contienen
MX168030B (es) Procedimiento para la preparacion de derivados de alcano y alcoxialcano
NO881616D0 (no) Middel til innsekts- og middbekjempelse.
ES2070238T3 (es) Emulsion de lipidos que contiene un analogo de prostaglandina.
ES2043863T3 (es) Procedimiento para preparar derivados de la 1,2,5,6-tetrahidropiridina.
NZ228065A (en) 1,2,4-triazinediones and parasiticidal compositions; processes for preparation
ES2032752T3 (es) Procedimiento de preparacion de derivados de la 1-bencenosulfonil-2-oxo-5-alcoxi-pirrolidina.
NZ216048A (en) Quinolylglycinamide derivatives, and pharmaceutical compositions containing such
NZ222185A (en) N-substituted methanesulphonamide derivatives, and anticancer compositions containing such
AR241024A1 (es) Composicion de peroxido de hidrogeno acuoso apropiada para dilucion,para formar composiciones detergentes liquidas o composiciones de blanqueo,que consiste esencialmente en (a) de 20 a 35% en peso, en base a la composicion , de peroxido de hidrogeno,(b)
ES545009A0 (es) Procedimiento de preparacion de nuevas fenil-naftiridinas.
IL68916A0 (en) Thieno-pyridinone derivative,its preparation and therapeutic compositions containing it
BR9408195A (pt) Conjugados de hirudina formados de uma hirudina e um ou vários compostos lipófilos e processo para a produção de conjugados de hirudina
KR880012226A (ko) 외 용 제
NO832723L (no) Fremgangsmaate for oksydasjon av vinylbenzenforbindelser
YU92390A (en) New derivatives of 9-alpha-hydroxy-3-oxo-2,24(25)-stigmastadien-26-ic acid and a process for obtaining
AR023332A1 (es) Compuestos derivados de benzamida sustituidos, proceso para su preparacion, formulaciones farmaceuticas que los comprenden, y metodo de tratamiento